Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.23 USD | -6.30% | +9.35% | +11.63% |
Jun. 06 | Morgan Stanley Adjusts Price Target on Vir Biotechnology to $15 From $12, Maintains Equal-Weight Rating | MT |
Jun. 05 | Sector Update: Health Care Stocks Steady Premarket Wednesday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.63% | 1.53B | |
+51.85% | 57.87B | |
+40.63% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Cytokinetics Appoints Sung Lee as CFO